Evidence map›Paper›PMID 38092661›Full record

ReviewJournal of virology2023

Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.

Esteban Domingo, Brenda Martínez-González, Carlos García-Crespo, Pilar Somovilla, Ana Isabel de Ávila, María Eugenia Soria, Antoni Durán-Pastor, Celia Perales

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Methods to Characterize Mutant Spectra of RNA Viruses: The Case of SARS-CoV-2.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Quasispecies productivity.Die Naturwissenschaften · 2024
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Esteban DomingoCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.ORCID 0000-0002-0573-1676
Brenda Martínez-GonzálezCentro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Carlos García-CrespoCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Pilar SomovillaCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Ana Isabel de ÁvilaCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
María Eugenia SoriaCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Antoni Durán-PastorCentro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.
Celia PeralesCentro Nacional de Biotecnología (CNB-CSIC), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, Madrid, Spain.ORCID 0000-0003-1618-1937
Consejo Superior de Investigaciones Científicas · ES

Funding

Comunidad de Madrid (Community of Madrid) 13-2022-008566Comunidad de Madrid (Community of Madrid) S2018/BAA-4370Fundacio La Marato de TV3 525/C/2021MEC | Consejo Superior de Investigaciones Científicas (CSIC) CSIC-COV19-014MEC | Instituto de Salud Carlos III (ISCIII) FI19/00119MEC | Instituto de Salud Carlos III (ISCIII) PI21/00139Ministerio de Ciencia e Innovación (MCIN) 202220I116Ministerio de Ciencia e Innovación (MCIN) PID2020-113888RB-I00Ministerio de Ciencia, Innovación y Universidades (MCIU) CA1/RSUE/2021Ministerio de Ciencia, Innovación y Universidades (MCIU) PRE2018-083422
6 · The paper itself

Abstract

Upon the emergence of SARS-CoV-2 in the human population, it was conjectured that for this coronavirus the dynamic intra-host heterogeneity typical of RNA viruses would be toned down. Nothing of this sort is observed. Here we review the main observations on the complexity and diverse composition of SARS-CoV-2 mutant spectra sampled from infected patients, within the framework of quasispecies dynamics. The analyses suggest that the information provided by myriads of genomic sequences within infected individuals may have a predictive value of the genomic sequences that acquire epidemiological relevance. Possibilities to reconcile the presence of broad mutant spectra in the large RNA coronavirus genome with its encoding a 3' to 5' exonuclease proofreading-repair activity are considered. Indeterminations in the behavior of individual viral genomes provide a benefit for the survival of the ensemble. We propose that this concept falls in the domain of "stochastic thinking," a notion that applies also to cellular processes, as a means for biological systems to face unexpected needs.

Indexed as

COVID-19RNA VirusesSARS-CoV-2Genome, ViralHumansQuasispeciescancer heterogeneitycoronavirusdeletionerror thresholdmutant spectrummutationprionultra-deep sequencingviral disease controlvirus complexity

Identifiers

PMID38092661
PMCPMC10734546
OpenAlexW4388865577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.